Biomedical Management

A broad category covering medical evaluations and interventions that target suspected physiological abnormalities associated with ASD (e.g., metabolic testing, immune or mitochondrial treatments, special diets, targeted supplements, or off-label therapies). Some elements are evidence-based; others are experimental or controversial.

Practitioners look for treatable medical issues (e.g., seizures, GI disease, nutrient deficiencies, cerebral folate deficiency) and use targeted interventions. Some approaches are standard medical care when a medical condition is identified; others (e.g., unproven “detox” regimens) lack strong evidence and can be risky. Biomedical care should be guided by qualified clinicians and targeted testing.

• If an underlying medical condition is found (e.g., seizure disorder, cerebral folate deficiency), treating it can improve functioning.

• Personalized medical assessment can catch treatable comorbidities that improve quality of life.

Risks depend on the specific intervention. Unproven therapies can cause harm, financial burden, nutritional imbalance, or delay evidence-based therapies. Clinical oversight, safety monitoring, and preference for interventions with good evidence are crucial.

References
Reviews of biomedical interventions and discussion of evidence/limitations. PMC+1